The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty throughout the month of May.
- The second annual will be returning in-person on September 23rd, 2024 聽in Cary, North Carolina.
- Millie Long, MD, MPH,聽 ultrasound training in NYC to better care for patients with IBD. She even fit a run in around Central Park.
- Stephan Moll, MD, collaborated with researchers from around the globe for “Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders,” published in the New England Journal of Medicine.
- Buer Sen, MD, Zhihui Xie, MD, Cody McGrath, Maya Styner, MD, and Janet Rubin, MD, in Nature Communications titled, “Nuclear actin structure regulates chromatin accessibility.”
- Janice Hwang, MD, MHS, was featured in a exploring how Ozempic has changed diabetes care.
- Yohei Hisada, PhD, Nigel Key, MD, and Nigel Mackman, PhD, “Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.” Their manuscript was accepted by The Journal of Thrombosis and Haemostasis.
- David Wohl, MD, on a legislative proposal to ban masking in public, saying it’s not a well thought-out approach.
- Nicholas Shaheen, MD, MPH, highlighting AI platform’s powerful diagnostic impact and ability enhance patient outcomes.
- Millie Long, MD, MPH, results from the TARGET-IBD study.
- Nirupama Ramadas, PhD, Fatima Trebak, PhD, Rafal Pawlinski, PhD, and Erin Sparkenbaugh, PhD, are co-authors of 鈥淏iased agonism of protease-activated receptor-1 regulates thrombo-inflammation in murine sickle cell disease.鈥� was accepted in Blood Advances, a journal of the American Society of Hematology.
- Walker Reed, MD, Robert Sandler, MD, MPH, and Anne Peery, MD, prevalence and odds of colorectal cancer in patients with diverticulitis.
- John Batsis, MD, the side effects older adults should be aware of before taking a GLP-1 like Ozempic.
- Nigel Key, MD, concerns related to cost and variabilty in results of gene therapy.